In this study, we found that the expression of the RNA-binding motif protein 15 (RBM15) m6A writer was significantly upregulated in triple-negative breast cancer (TNBC) cells and was closely associated with clinical outcomes. Here, RBM15 is linked to triple-negative breast carcinoma.